Immunotherapy for infectious diseases represents a cutting-edge approach to combatting microbial pathogens by harnessing the body's immune system. Unlike traditional antimicrobial agents, which directly target pathogens, immunotherapy focuses on bolstering the host's immune response to better eliminate invading microbes. This strategy involves various interventions, including vaccines, monoclonal antibodies, and immune modulators, designed to enhance the body's ability to recognize and neutralize infectious agents. For instance, vaccines stimulate the production of pathogen-specific antibodies and memory T-cells, providing long-term protection against future infections. Similarly, monoclonal antibodies can directly target and neutralize microbial toxins or virulence factors, mitigating disease severity. By leveraging the power of immunotherapy, researchers aim to develop novel strategies for preventing and treating a wide range of infectious diseases, potentially revolutionizing the field of infectious disease management.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States